Crossmark

Higher risk of gastrointestinal stenosis and obstruction in clozapine-treated individuals with schizophrenia: a pharmacovigilance study based on the FDA adverse event reporting system database

Crossref DOI link: https://doi.org/10.1007/s00210-025-04481-5

Published Online: 2025-07-30

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Dandan

Zhao, Zilong

Chen, Zhenhui

Qiao, Zhenzhen

He, Yao

Zhou, Jianxing

Zheng, Xiaoyuan
Funding

Funding for this research was provided by:

Chongqing Clinical Pharmacy Key Specialties Construction Project
License Information

Text and Data Mining valid from 2025-07-30

Version of Record valid from 2025-07-30
More Information

Article History

Received: 2 June 2025

Accepted: 16 July 2025

First Online: 30 July 2025

Declarations

:

: The authors declare no competing interests.

: Ethical approval was not required as the study was conducted using de-identified publicly available data.

: This manuscript has not been published or presented elsewhere in part or in entirety and is not under consideration by another journal.

Document is current

Any future updates will be listed below